With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|GSTM4, a novel target for treating Ewing sarcoma.||Huntsman Cancer Institute / Wen Luo||Young Investigator Grants||2009||Utah|
|Aberrant DNA methylation in Ewing sarcoma.||Fred Hutchinson Cancer Research Center / Scott Borinstein||Young Investigator Grants||2009||Washington|
|Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies||Dana-Farber Cancer Institute / Ujwal Pyati||Young Investigator Grants||2009||Massachusetts|
|Identification of proteins interacting with ALK in neuroblastoma.||Dana-Farber Cancer Institute / Rani George||Young Investigator Grants||2009||Massachusetts|
|Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors||Children's National Medical Center / Suzanne Miles||Young Investigator Grants||2009||District of Columbia|
|MLL-based chromosomal translocations in the pathogenesis of childhood leukemia.||Children's Mercy / Erin Guest||Young Investigator Grants||2009||Missouri|
|DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.||Cancer Research Center of Hawaii / Dana-Lynn Koomoa||Young Investigator Grants||2009||Hawaii|
|Biology-based clinical trials for children with cancer.||Children's Hospital of Philadelphia / Rochelle Bagatell||Phase I/II Infrastructure Grants||2009||Pennsylvania|
|Development of a childhood leukemia translational research program.||Dana-Farber Cancer Institute / Lewis Silverman||Phase I/II Infrastructure Grants||2009||Massachusetts|
|Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2009||Colorado|